Description

The number of children taking second-generation antipsychotics (SGA) is increasing. While SGAs produce fewer neurological side effects, the metabolic side effects of SGAs increase the risk for future cardiometabolic disease.

Downloads
pdf (896 KB)

Download count: 0

Details

Contributors
Date Created
2018-04-21
Resource Type
  • Text
  • Collaborating institutions
    College of Nursing and Health Innovation

    Machine-readable links